Lloyd Price

MARCH 1, 2025

Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. The higher revenue multiple for HealthTech companies reflects the fact that the healthcare market is growing rapidly and there is a lot of demand for innovative digital health solutions.

Telehealth 72

Telehealth Digital Health Leadership Interoperability 72

Healthcare IT Today

MARCH 13, 2025

Together with GPG Ventures and AI Fund, their support reflects solid investor confidence in Affineons market leadership and momentum. With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digital health, medtech, consumer health, and general B2B tech.

BioTech 52

BioTech EHR Leadership Patient Experience 52

Health Populi

MARCH 11, 2021

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.

Health Policy 254

Health Policy Medicare Pharmaceuticals Life Science 254

Lloyd Price

FEBRUARY 23, 2025

These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.

Telehealth 74

Telehealth Leadership Digital Health BioTech 74

Digital Health Global

MARCH 27, 2024

“In only seven years, Health+Commerce has built a highly respected organization providing strategic programs that reach clinician, investor and consumer audiences in the multibillion-dollar medtech, biotech and digital health sectors. We look forward to supporting the agency as it continues on its growth trajectory.”

Life Science 88

Life Science BioTech Leadership Digital Health 88

Lloyd Price

DECEMBER 2, 2024

Digital Health Solutions: Digital health solutions are gaining traction in wound care, enabling remote monitoring, telemedicine consultations, and data-driven decision-making. Innovative technologies and digital health solutions can help reduce costs and improve efficiency. Subscribe Today!

Digital Health 57

Digital Health healthcare technology Telemedicine Leadership 57

Digital Health Global

JUNE 20, 2023

Earlier in his career, Mr. Kamkolkar served in enterprise data science, digital & AI leadership roles at Sanofi and Novartis. Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. Jane Rhodes, Ph.D., Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Digital Health Global

AUGUST 2, 2023

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He Colin has demonstrated strong leadership to his teams and customers alike.” Colin has demonstrated strong leadership to his teams and customers alike.” “I

BioTech 88

BioTech Digital Health Pharmaceuticals healthcare technology 88

Health Populi

MARCH 19, 2019

For the organization’s 2020 vision, there are three category pillars in sight: over-the-counter (OTC) drugs (the core mission for over a century), dietary supplements, and consumer medical devices (think: the CES digital health aisles, and beyond). Consumer health went opposite, up 7 points, biotech up 3, insurance up 8, pharma up 6.

BioTech 159

BioTech Life Science Leadership Medicare 159

Digital Health Global

MARCH 2, 2023

We particularly see the collaboration as mutually beneficial to many of our rare-disease client partners, in alignment with our growing digital health practice.” “We Our engagement over the past year in scaling and expanding Koneksa’s medical function, under the leadership of Koneksa Chief Medical Officer Dr.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Digital Health Global

MARCH 1, 2023

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. We are pleased to welcome Julie Xing to our Board of Directors.

Pharmaceuticals 68

Pharmaceuticals Leadership BioTech Digital Health 68

Digital Health Global

FEBRUARY 5, 2024

At Solas, we invest in game-changing healthcare innovation and strong leadership teams committed to creating meaningful patient impact,” said Dr. David Adair, Managing Director of Solas BioVentures. The Solas investment team combines decades of clinical, regulatory and operating experience across different verticals in healthcare.

Life Science 88

Life Science Pharmaceuticals Medical Technology BioTech 88

Digital Health Global

APRIL 12, 2023

Some of the greatest innovation, with the highest potential for societal and economic impact, is happening in digital health, biotech and climate right now,” said Simmons, founder and managing partner at Overwater Ventures. “I Simmons has deep tenure in venture capital and brand building.

BioTech 88

BioTech Mental health Leadership Digital Health 88

Digital Health Global

MARCH 4, 2024

Cerula Care is a virtual behavioral healthcare practice that partners with specialists and tailors behavioral health care for adults with serious illness. Cerula Care is using AI/ML modeling to fuel clinical and cost outcomes related to improvement in behavioral health and reduction in hospitalizations.

Mental health 88

Mental health BioTech Psychiatry Digital Health 88

Digital Health Global

FEBRUARY 7, 2023

3CC prioritizes early-stage investments in “Third Culture entrepreneurs” whose unique perspectives have the potential to help transform healthcare and address health disparities by optimizing care delivery in healthtech and biotech. Ciba Health was recently named among NY Digital Health 100 winners for 2023.

Chronic pain management 88

Chronic pain management BioTech Pain management Healthcare Innovation 88

Lloyd Price

SEPTEMBER 30, 2024

Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Why Healthcare?

BioTech 57

BioTech Pharmaceuticals Leadership healthcare technology 57

Lloyd Price

MAY 5, 2024

HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit www.nelsonadvisors.co.uk Subscribe Today! Email lloyd@nelsonadvisors.co.uk Subscribe Today!

healthcare technology 65

healthcare technology Life Science Leadership BioTech 65

Lloyd Price

FEBRUARY 13, 2024

Exec Summary: Scotland has emerged as a global leader in the field of digital health and care, driven by a combination of factors: A strong foundation in medical innovation: Scotland boasts a rich history of medical breakthroughs, from the world's first cloned sheep (Dolly) to pioneering research in stem cell therapy.

Healthcare Innovation 65

Healthcare Innovation Digital Health Life Science healthcare technology 65

Digital Health Global

MARCH 16, 2023

Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our We believe our pioneering technology will allow us to shatter the boundaries that exist in gene editing methods today,” said Anne-K.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Lloyd Price

FEBRUARY 14, 2019

Digital health is expected to be a $379bn market by 2024, with truly global and society-shaping potential. “[The As a result, more and more investors are paying attention to the health sector which, due to its complexity, has traditionally been left to biotech or medical devices investors.

BioTech 53

BioTech Digital Health Leadership Nursing 53

mHealth Insight

FEBRUARY 21, 2019

Best Mobile Innovation for Health and BioTech c. Digital Health and Wellness Summit. Centre for Information Policy Leadership. There are a number of start-ups and partnerships with operators, that point to scalable, sustainable and commercially viable use cases for digital health and wellbeing.

mHealth 28

mHealth Digital Health Health science BioTech 28

Digital Health Global

MAY 8, 2023

“BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades.

Pharmaceuticals 88

Pharmaceuticals Life Science BioTech Leadership 88

Lloyd Price

JUNE 22, 2024

Exec Summary: The digital health IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted since then. Why did so many Digital Health companies go public in 2021? There were a confluence of factors that fueled the surge of digital health companies going public in 2021: 1.

Digital Health 69

Digital Health healthcare technology Primary Care Telehealth 69

Lloyd Price

NOVEMBER 4, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Digital Health 69

Digital Health healthcare technology Leadership Telehealth 69